UK News Archive

The UK News Archive contains resources intended for journalists only.

2022

August

Media Release / Aug 11, 2022

MHRA grants marketing authorisation for Novartis’ radioligand therapy Pluvicto®▼ (lutetium (¹⁷⁷Lu) vipivotide tetraxetan) in advanced prostate cancer in Great Britain

Read More

July

Media Release / Jul 28, 2022

NICE recommends Novartis Beovu® (brolucizumab) for thousands with sight loss due to diabetes

Read More
Media Release / Jul 14, 2022

NICE recommends Novartis’ Piqray ® (alpelisib) as a targeted treatment for thousands of advanced breast cancer patients

Read More
Media Release / Jul 11, 2022

Scottish Medicines Consortium issues interim acceptance to Novartis’ Adakveo®▼ (crizanlizumab) for preventing recurrent vaso-occlusive crises, the first treatment for sickle cell disorder in over 20 years

Read More
Media Release / Jul 05, 2022

Novartis Pharmaceuticals UK launches world-first health-tech investor partnership to reimagine cardiovascular care

Read More

June

Media Release / Jun 30, 2022

First STAMP (specifically targeting the abl myristoyl pocket) inhibitor for treatment for chronic myeloid leukaemia (CML), Scemblix®▼ (asciminib) receives NICE final draft recommendation in Great Britain

Read More
Media Release / Jun 16, 2022

Novartis receives GB licence for Scemblix®▼ (asciminib), the first STAMP inhibitor for patients with chronic myeloid leukaemia

Read More
Story / Jun 01, 2022

Marie- Andrée Gamache appointed Country President, Novartis Innovative Medicines, UK & Ireland

Read More

May

Media Release / May 26, 2022

Novartis UK launches new heart failure insights tool to address health inequalities in England

Read More
Media Release / May 13, 2022

Novartis UK statement on Tegretol stock

Read More

Related Links